About This Page
This is a clinician-written, evidence-based summary aligned to the USMLE Step 2 CK Content Outline. It is intended for medical students preparing for USMLE Step 2 CK. Management reflects current ACC/AHA, USPSTF, and APA guidelines. Always cross-reference with UpToDate, institutional protocols, and clinical judgment.
The Bottom Line
- Physiologic jaundice appears after 24 hours, peaks around day 3-5, and resolves over 1-2 weeks in term infants
- Jaundice in the first 24 hours is pathologic until proven otherwise — think hemolysis, infection, or congenital disease
- AAP 2022 management uses hour-specific bilirubin thresholds adjusted for gestational age and neurotoxicity risk factors
- Phototherapy is first-line for significant unconjugated hyperbilirubinemia; exchange transfusion is for severe levels or acute bilirubin encephalopathy
- Direct hyperbilirubinemia is never physiologic and requires evaluation for cholestasis, biliary atresia, infection, or metabolic disease
Overview
Neonatal jaundice is common because newborns produce more bilirubin, have immature hepatic conjugation, and undergo enterohepatic circulation. The key clinical task is distinguishing benign physiologic unconjugated hyperbilirubinemia from pathologic jaundice that can cause bilirubin-induced neurologic dysfunction. The 2022 AAP guideline emphasizes universal predischarge bilirubin measurement, gestational-age-specific thresholds, risk-factor adjustment, and coordinated follow-up based on how close the bilirubin is to the phototherapy threshold.
Epidemiology
Most term newborns develop visible jaundice in the first week of life, but only a minority require phototherapy. Severe hyperbilirubinemia is more common with prematurity, exclusive breastfeeding with poor intake, hemolysis, G6PD deficiency, significant bruising or cephalohematoma, East Asian ancestry, and sibling history requiring phototherapy. Kernicterus is rare in high-resource settings but remains devastating and preventable.
Clinical Features
Symptoms
Yellow skin or sclera progressing from face downward
Poor feeding, lethargy, hypotonia, high-pitched cry, or irritability
Jaundice within the first 24 hours of life
Dark urine or pale stools suggesting conjugated hyperbilirubinemia/cholestasis
Excessive weight loss or inadequate stooling in breastfed infant
Family history of phototherapy, G6PD deficiency, hereditary spherocytosis, or hemolytic disease
Signs
Cephalocaudal jaundice; visual estimate is unreliable and should be confirmed with bilirubin measurement
Cephalohematoma, extensive bruising, or subgaleal hemorrhage increasing bilirubin load
Hepatosplenomegaly, pallor, or petechiae suggesting hemolysis, infection, or congenital disease
Opisthotonos, retrocollis, seizures, or abnormal tone = acute bilirubin encephalopathy
Pale acholic stools or hepatomegaly suggesting biliary atresia or neonatal cholestasis
Investigations
First-line
Total serum bilirubin or transcutaneous bilirubinObtain hour-specific bilirubin; serum bilirubin is required near treatment thresholds and for treatment decisions
Direct bilirubinIf jaundice is prolonged, stools are pale, urine is dark, hepatomegaly is present, or infant appears ill; direct hyperbilirubinemia is pathologic
Blood type and direct antiglobulin testAssess ABO/Rh incompatibility and immune hemolysis when early or significant jaundice is present
CBC, reticulocyte count, peripheral smearEvaluate anemia, hemolysis, spherocytes, or infection when jaundice is early, rapidly rising, or severe
Second-line
G6PD testingConsider in severe, unexplained, or recurrent hyperbilirubinemia, especially with relevant ancestry or poor phototherapy response
Sepsis evaluationIll appearance, temperature instability, poor feeding, lethargy, or risk factors require cultures and empiric antibiotics
TSH/free T4 or newborn screen reviewCongenital hypothyroidism can present with prolonged jaundice
Specialist
Pediatric gastroenterology/surgeryDirect hyperbilirubinemia, pale stools, or persistent jaundice beyond expected period requires urgent evaluation for biliary atresia
NeonatologyBilirubin at escalation-of-care or exchange thresholds, acute bilirubin encephalopathy, or hemolytic disease requiring IVIG/exchange transfusion
1
Risk stratification
- Determine gestational age, postnatal age in hours, bilirubin level, and neurotoxicity risk factors
- Risk factors include gestational age <38 weeks, albumin <3 g/dL, isoimmune hemolytic disease, G6PD deficiency, sepsis, and clinical instability
- Measure bilirubin before discharge and schedule follow-up based on how close the value is to the treatment threshold
2
Phototherapy
- Use intensive phototherapy when total serum bilirubin reaches AAP threshold for age, gestational age, and risk status
- Maximize exposed skin, irradiance, and treatment surface area; continue feeding support and monitor hydration
- Repeat bilirubin based on level and trajectory; rebound checks are needed for high-risk infants after stopping phototherapy
3
Escalation and exchange transfusion
- Escalation-of-care threshold is close to exchange level and requires urgent neonatology involvement
- IV hydration, intensive phototherapy, frequent bilirubin measurement, and preparation for exchange transfusion
- IVIG may be considered for isoimmune hemolytic disease if bilirubin reaches escalation threshold despite intensive phototherapy
- Exchange transfusion is indicated for severe hyperbilirubinemia at exchange threshold or signs of acute bilirubin encephalopathy
4
Feeding and follow-up
- Support breastfeeding; assess latch, milk transfer, stool/urine output, and weight loss
- Supplementation may be needed if intake is inadequate and bilirubin is rising near treatment thresholds
- Do not treat direct hyperbilirubinemia with phototherapy alone; evaluate for cholestasis and biliary atresia
Complications
- Acute bilirubin encephalopathy: Lethargy, hypotonia, high-pitched cry, poor feeding, progressing to hypertonia, opisthotonos, fever, and seizures
- Kernicterus: Chronic bilirubin neurotoxicity with choreoathetoid cerebral palsy, sensorineural hearing loss, gaze abnormalities, and dental enamel dysplasia
- Missed biliary atresia: Delayed diagnosis can lead to progressive cirrhosis and worse Kasai portoenterostomy outcomes
- Dehydration and hypernatremia: Breastfeeding failure jaundice can coexist with excessive weight loss and poor intake
- Hemolytic anemia: ABO/Rh disease, G6PD deficiency, or hereditary spherocytosis may require disease-specific management
USMLE Step 2 CK Exam Tips
- 1Jaundice in the first 24 hours is pathologic — do not call it physiologic jaundice
- 2Physiologic jaundice is unconjugated, starts after 24 hours, peaks day 3-5, and the infant is otherwise well
- 3Direct hyperbilirubinemia is never physiologic; pale stools and dark urine = cholestasis/biliary atresia workup
- 4Phototherapy converts unconjugated bilirubin into water-soluble isomers; it is not treatment for biliary obstruction
- 5ABO incompatibility can occur in first pregnancy; Rh disease usually requires prior sensitization unless prophylaxis failed
- 6Kernicterus classically affects basal ganglia and cranial nerve nuclei — high-pitched cry, opisthotonos, seizures are late red flags
- 7Breastfeeding failure jaundice = poor intake early; breast milk jaundice = well infant with prolonged unconjugated jaundice after day 5-7
practicetest your knowledge on neonatal jaundiceApply what you've learnt with USMLE Step 2 CK-style questions from the iatroX Q-Bank — pediatrics and beyond.
open q-bank